Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Megetra 160mg Tablet

Prescription Icon
Prescription Required

Marketer

Getwell Pharma (I) Pvt Ltd

Salt Composition

Megestrol (160mg)

Overview Megetra 160mg Tablet

Medrolin 160mg tablets are indicated for the management of hormone-receptor-positive breast and endometrial cancers. This medication can also address decreased appetite and weight loss associated with advanced cancer or HIV. Dosage and duration of Medrolin 160mg therapy should be determined by your physician. Administration with or without food is acceptable, though consistent timing is recommended. Continue treatment as directed. Frequently reported side effects include increased appetite and weight, dyspnea, vasomotor flushes, hypertension, and constipation. These are usually transient, resolving with continued treatment. Report any persistent or troublesome side effects to your doctor; management strategies may be available. Inform your physician of all concurrent medications, as interactions may affect Medrolin's efficacy or pharmacokinetics. This medication is contraindicated during pregnancy and lactation. Regular blood tests to monitor hormone and glucose levels may be conducted during treatment.

Primary Ingredients of Megetra 160mg Tablet

No text provided to rephrase.

Uses of Megetra 160mg Tablet

Cancers of the breast and uterine lining

Major Benefits of Megetra 160mg Tablet:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megetra 160mg Tablets can be consumed with or without food, although consistent timing is recommended.

Common Side effects of Megetra 160mg Tablet:

  • Increased appetite
  • Weight gain
  • Hot flashes
  • High blood pressure
  • Constipation

How to use Megetra 160mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the 160mg Megetra tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.

How Megetra 160mg Tablet works:

Megetra 160mg tablets contain a progestin, a type of female hormone. In individuals with breast or endometrial cancer, this medication modifies hormone levels implicated in tumor development. A potential side effect is weight increase, often linked to heightened appetite.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Megetra 160mg Tablet may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancyUNSAFE

Use of Megetra 160mg tablets is strongly contraindicated during pregnancy. Pregnant women should consult their physician; animal and human studies reveal substantial risks to fetal development.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Megetra 160mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Megetra 160mg Tablets.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Megetra 160mg tablets. Dosage modification for Megetra 160mg tablets may be necessary; physician consultation is advised.

LiverLiverCAUTION

Patients with severe hepatic impairment should exercise caution when using Megetra 160mg tablets. Dosage modification for Megetra 160mg tablets may be necessary. Physician consultation is advised.

What if you forget to take Megetra 160mg Tablet :

NA

Facts to Know About Megetra 160mg Tablet

LabelValue
Chemical Classification Synthetic Progestins
Developing Habits No.
Type of Therapy Cancer Medications

FAQs on Megetra 160mg Tablet

Megestrol 160mg Tablets contain megestrol, a progesterone-like hormone. This medication treats hormone-dependent breast and endometrial cancers. It's also used to increase appetite and weight in individuals with AIDS.
Megetra 160mg Tablets can commonly cause weight gain, often resulting from increased appetite and subsequent increases in fat and body mass. Consult your doctor about significant weight gain. This medication treats malnutrition, appetite loss, and severe weight loss in AIDS patients, but isn't for preventing weight loss.
Take Megetra 160mg Tablet as directed by your doctor. It can be taken anytime, with or without food, but consistency (e.g., at the same time daily) aids in remembering your dose. Swallow the tablet whole with water. If unsure, consult your doctor.
Megetra 160mg Tablets don't halt menstruation, but can disrupt your cycle, potentially causing breakthrough bleeding. This limits its use in HIV-positive women. Consult your doctor if breakthrough bleeding occurs during treatment.
Megetra 160mg tablets are not chemotherapy. They're a synthetic progesterone hormone used to treat breast and endometrial (uterine) cancers by altering hormones that contribute to cancer growth.
Don't take Megetra 160mg Tablet if you're pregnant or planning to become pregnant. If pregnancy occurs while taking it, contact your doctor immediately, as it may harm your unborn child, potentially causing sex organ abnormalities in male and female babies if taken during the first trimester. Your doctor will likely recommend a pregnancy test before starting treatment.
Megetra 160mg Tablets do not prevent pregnancy. While they might alter your menstrual cycle, they offer no contraceptive protection. Therefore, use a reliable birth control method. Consult your doctor if you have any questions or concerns.
Megestrol 160mg Tablets contain megestrol, a progesterone-like hormone. This medication treats hormone-sensitive breast and endometrial cancers. It's also used to stimulate appetite and weight gain in individuals with AIDS.
Megetra 160mg Tablets do not require refrigeration. Store below 25°C in the original packaging to protect from moisture.
Megetra 160mg Tablets are not approved for treating hot flashes. Consult your doctor before use. While estrogen (women) and androgen (men) are typically used for hot flashes, they're contraindicated in individuals with breast (female) or prostate (male) cancer.
Megetra 160mg Tablet
648
MRP 750
13% off